Left Ventricular Outflow Tract Obstruction as a Risk Factor for Sudden Cardiac Death in Hypertrophic Cardiomyopathy

American Journal of Cardiology

Volumn 104, Issue 5, 2009, Pages 695-699

  Efthimiadis, Georgios K ^a   Parcharidou, Despina G ^a   Giannakoulas, Georgios ^a   Pagourelias, Efstathios D ^a   Charalampidis, Panagiotis ^a   Savvopoulos, Gregorios ^a   Ziakas, Antonios ^a   Karvounis, Haralambos ^a   Styliadis, Ioannis H ^a   Parcharidis, Georgios E ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DEFIBRILLATOR; ECHOCARDIOGRAPHY; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HEART ARREST; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; PRIORITY JOURNAL; RISK FACTOR; SUDDEN DEATH; SYNCOPE;

ADULT; AGED; CARDIOMYOPATHY, HYPERTROPHIC; DEATH, SUDDEN, CARDIAC; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; VENTRICULAR OUTFLOW OBSTRUCTION;

EID: 68949188142     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.04.039     Document Type: Article

References (21)

1. Spirito P., Seidman C.E., McKenna W.J., and Maron B.J. The management of hypertrophic cardiomyopathy. N Engl J Med 336 (1997) 775-785
2. Autore C., Bernarbò P., Barillà C.S., Bruzzi P., and Spirito P. The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms. J Am Coll Cardiol 45 (2005) 1076-1108
3. Maron M.S., Olivotto I., Betocchi S., Casey S.A., Lesser J.R., Losi M.A., Cecchi F., and Maron B.J. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med 348 (2003) 295-303
4. Elliott P.M., Gimeno J.R., Tomé M.T., Shah J., Ward D., Thaman R., Mogensen J., and McKenna W.J. Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy. Eur Heart J 27 (2006) 1933-1941
5. Maron B.J., Bonow R.O., Cannon III R.O., Leon M.B., and Epstein S.E. Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy. N Engl J Med 316 (1987) 780-789
6. Maron B.J., Gottdiener J.S., and Epstein S.E. Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a wide angle, two dimensional echocardiographic study of 125 patients. Am J Cardiol 48 (1981) 418-428
7. Elliott P.M., Poloniecki J., Dickie S., Sharma S., Monserrat L., Varnava A., Mahon N.G., and McKenna W.J. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol 36 (2000) 2212-2218
8. Sahn D.J., DeMaria A., Kisslo J., and Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58 (1978) 1072-1083
9. Panza J.A., Petrone R.K., Fananapazir L., and Maron B.J. Utility of continuous wave Doppler echocardiography in the noninvasive assessment of left ventricular outflow tract pressure gradient in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 19 (1992) 91-99
10. Maron B.J. Hypertrophic cardiomyopathy: a systematic review. JAMA 287 (2002) 1308-1320
11. McCully R.B., Nishimura R.A., Tajik A.J., Schaff H.V., and Danielson G.K. Extent of clinical improvement after surgical treatment of hypertrophic obstructive cardiomyopathy. Circulation 94 (1996) 467-471
12. Qin J.X., Shiota T., Lever H.M., Kapadia S.R., Sitges M., Rubin D.N., Bauer F., Greenberg N.L., Agler D.A., Drinko J.K., Martin M., Tuzcu E.M., Smedira N.G., Lytle B., and Thomas J.D. Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery. J Am Coll Cardiol 38 (2001) 1994-2000
13. Maron B.J., Olivotto I., and Maron M.S. The dilemma of left ventricular outflow tract obstruction and sudden death in hypertrophic cardiomyopathy: do patients with gradients really deserve prophylactic defibrillators?. Eur Heart J 27 (2006) 1895-1897
14. Maron M.S., Olivotto I., Zenovich A.G., Link M.S., Pandian N.G., Kuvin J.T., Nistri S., Cecchi F., Udelson J.E., and Maron B.J. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation 114 (2006) 2232-2239
15. Maron B.J., Shen W.K., Link M.S., Epstein A.E., Almquist A.K., Daubert J.P., Bardy G.H., Favale S., Rea R.F., Boriani G., Estes III N.A., and Spirito P. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 342 (2000) 365-373
16. Varnava A.M., Elliott P.M., Mahon N., Davies M.J., and McKenna W.J. Relation between myocyte disarray and outcome in hypertrophic cardiomyopathy. Am J Cardiol 88 (2001) 275-279
17. Choudhury L., Mahrholdt H., Wagner A., Choi K.M., Elliott M.D., Klocke F.J., Bonow R.O., Judd R.M., and Kim R.J. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 40 (2002) 2156-2164
18. Kwon D.H., Setser R.M., Popović Z.B., Thamilarasan M., Sola S., Schoenhagen P., Garcia M.J., Flamm S.D., Lever H.M., and Desai M.Y. Association of myocardial fibrosis, electrocardiography and ventricular tachyarrhythmia in hypertrophic cardiomyopathy: a delayed contrast enhanced MRI study. Int J Cardiovasc Imaging 24 (2008) 617-625
19. Adabag A.S., Maron B.J., Appelbaum E., Harrigan C.J., Buros J.L., Gibson C.M., Lesser J.R., Hanna C.A., Udelson J.E., Manning W.J., and Maron M.S. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol 51 (2008) 1369-1374
20. Javadpour M.M., Tardiff J.C., Pinz I., and Ingwall J.S. Decreased energetics in murine hearts bearing the R92Q mutation in cardiac troponin T. J Clin Invest 112 (2003) 768-775
21. Efthimiadis GK, Pagourelias ED. Delayed hyperenhancement magnetic resonance imaging for sudden cardiac death risk stratification in hypetrophic cardiomyopathy. J Am Coll Cardiol. In press.